Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q3 2021 vs. Q2 2021
How the institutions holding Cidara Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 55 | 50 | −5 |
| Shares | 20.0M | 18.8M | −1.23M (−6.2%) |
| Value | $40.5M | $42.1M | +$1.64M (+4.1%) |
New holders (8)
Institutions that held Cidara Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Monashee Investment Management LLC | 369,099 | $827.0K | 0.15% |
| Marshall Wace, LLP | 184,027 | $412.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 53,431 | $120.0K | 0.00% |
| Kestra Advisory Services, LLC | 30,500 | $68.0K | 0.00% |
| Aveo Capital Partners, LLC | 22,502 | $50.0K | 0.01% |
| Dimensional Fund Advisors LP | 12,326 | $28.0K | 0.00% |
| Group One Trading, L.P. | 11,548 | $26.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,881 | $11.0K | 0.00% |
Sold out (13)
Institutions that held Cidara Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Interwest Venture Management Co | 1,356,813 | $2.74M |
| Tibra Equities Europe Ltd | 174,900 | $353.0K |
| Opaleye Management Inc. | 73,351 | $148.0K |
| Parametric Portfolio Associates LLC | 34,001 | $69.0K |
| XTX Topco Ltd | 25,971 | $52.0K |
| Charles Schwab Investment Management Inc | 25,006 | $51.0K |
| Pitcairn Co | 23,161 | $47.0K |
| LMR Partners LLP | 10,852 | $22.0K |
| Citigroup Inc | 4,000 | $8.00K |
| UBS Asset Management Americas Inc | 2,927 | $5.91K |
| Royal Bank of Canada | 1,980 | $4.00K |
| Isthmus Partners, LLC | 2,000 | $4.00K |
| New York State Common Retirement Fund | 283 | $1.00K |